Gene · 10153
Papers2,237
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
301 to 320 of 2,237
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mapping of the QTLs governing grain micronutrients and thousand kernel weight in wheat (Triticum aestivum L.) using high density SNP markers. | Front Nutr | 2023 | 36845058 | PubTator, text mining | PubMed |
| Whole-genome re-sequencing, diversity analysis, and stress-resistance analysis of 77 grape rootstock genotypes. | Front Plant Sci | 2023 | 36844076 | PubTator, text mining | PubMed |
| Measurable Residual Disease (MRD) as a Surrogate Efficacy-Response Biomarker in AML. | Int J Mol Sci | 2023 | 36834477 | PubTator, text mining | PubMed |
| Combining the HCT-CI, G8, and AML-Score for Fitness Evaluation of Elderly Patients with Acute Myeloid Leukemia: A Single Center Analysis. | Cancers (Basel) | 2023 | 36831347 | PubTator, text mining | PubMed |
| The RUNX/CBFβ Complex in Breast Cancer: A Conundrum of Context. | Cells | 2023 | 36831308 | PubTator, text mining | PubMed |
| Critical Roles of METTL3 in Translation Regulation of Cancer. | Biomolecules | 2023 | 36830614 | PubTator, text mining | PubMed |
| Research progress on molecular biomarkers of acute myeloid leukemia. | Front Oncol | 2023 | 36824144 | PubTator, text mining | PubMed |
| Nanoparticle-mediated targeting of the fusion gene RUNX1/ETO in t(8;21)-positive acute myeloid leukaemia. | Leukemia | 2023 | 36823395 | PubTator, text mining | PubMed |
| Acute Myeloid Leukaemia With Translocation (8;21) Masquerading as Peripheral Blood Eosinophilia Having Dysplastic Features: A Diagnostic Challenge. | Cureus | 2023 | 36819451 | PubTator, text mining | PubMed |
| Proteomic Characterization of Acute Myeloid Leukemia for Precision Medicine. | Mol Cell Proteomics | 2023 | 36805445 | PubTator, text mining | PubMed |
| Core-binding factor fusion downregulation of ADAR2 RNA editing contributes to AML leukemogenesis. | Blood | 2023 | 36796022 | PubTator, text mining | PubMed |
| Midostaurin in addition to intensive chemotherapy in acute myeloid leukemia with t(8;21) and KIT and/or FLT3- ITD mutations: results of the SAL MIDOKIT trial. | Haematologica | 2023 | 36779591 | PubTator, text mining | PubMed |
| Pediatric Acute Myeloid Leukemia Post Cytotoxic Therapy-Retrospective Analysis of the Patients Treated in Poland from 2005 to 2022. | Cancers (Basel) | 2023 | 36765692 | PubTator, text mining | PubMed |
| Ribosome biogenesis factors-from names to functions. | EMBO J | 2023 | 36762427 | PubTator, text mining | PubMed |
| The chromatin-associated RNAs in gene regulation and cancer. | Mol Cancer | 2023 | 36750826 | PubTator, text mining | PubMed |
| Discovering novel clues of natural selection on four worldwide goat breeds. | Sci Rep | 2023 | 36747064 | PubTator, text mining | PubMed |
| Immune therapy: a new therapy for acute myeloid leukemia. | Blood Sci | 2023 | 36742185 | PubTator, text mining | PubMed |
| Computational approaches for the design of modulators targeting protein-protein interactions. | Expert Opin Drug Discov | 2023 | 36715303 | PubTator, text mining | PubMed |
| Targeting Pim kinases in hematological cancers: molecular and clinical review. | Mol Cancer | 2023 | 36694243 | PubTator, text mining | PubMed |
| Synergistic Targeting of DNA-PK and KIT Signaling Pathways in KIT Mutant Acute Myeloid Leukemia. | Mol Cell Proteomics | 2023 | 36682716 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10153/papers?page=16